“We are excited to offer innovative software and services to meet the needs of sleep specialists. Our customizable reports and role-based account profiles make our web-based software offerings stand out from the competition, and provide sleep specialists tools to expand their practice and partner with referring providers in new ways”.
CleveMed, Cleveland, OH – September 10, 2018 – CleveMed is pleased to announce a major update to its web-based scoring and reporting software for SleepView home sleep apnea test equipment. The overall speed of the system has been improved in all aspects of data review, scoring and reporting, saving significant time and streamlining the experience for sleep technologists and interpreting physicians. A new simple reporting tool provides physicians with capability to save common interpretation and treatment statements which are easily placed in the report for each patient.
“We are excited to offer innovative software and services to meet the needs of sleep specialists. Our customizable reports and role-based account profiles make our web-based software offerings stand out from the competition and provide sleep specialists tools to expand their practice and partner with referring providers in new ways”, said Sarah Weimer, CleveMed director of sleep services and products. “The cloud software includes the option to add SleepView Direct service, with monitors mailed from CleveMed directly to patients, while maintaining scoring and interpretation of those studies by your sleep specialists. This will allow sleep lab or specialists to easily service distant patients or prevent losing business to national mail order providers”.
CleveMed’s SleepView is the smallest and lightest sleep monitor on the market that exceeds the American Academy of Sleep Medicine guidelines. Its mail order program has been growing at a double digit rate every month for the past 5 quarters. CleveMed has offered web-based software for home sleep apnea testing since 2011.
Obstructive sleep apnea (OSA), the most prevalent form of sleep apnea, is a repeated interruption of normal breathing during sleep due to a collapse of the upper airway. It is estimated to impact as many people as asthma and diabetes; yet, up to 80 percent of the population with the disease remain undiagnosed and untreated. Moreover, OSA leads to serious health and economic consequences. Numerous studies link OSA to major chronic diseases such as stroke, heart failure, diabetes, obesity, hypertension and increased odds of serious car crash injuries.
CleveMed is a fast growing company with a wide range of sleep testing equipment, services, and cloud based technologies that allow sleep disorders to be monitored in the home, including Sapphire PSG™, SleepScout™, SleepView®, SleepView℠ Web-portal, and SleepView℠ Direct. CleveMed’s goal is to expand the reach of sleep medicine with technologies that speed diagnosis for providers, reduce healthcare costs for payers, and improve patients’ experiences in the home. For more information, please visit https://CleveMed.com (Follow us on twitter, youtube, LinkedIn, and facebook). SleepView is a registered trademark and a service mark, and Sapphire PSG and SleepScout are trademarks of Cleveland Medical Devices Inc. of Cleveland, OH.